Journavx (suzetrigine) - Vertex
Evaluation of the Excretion of Suzetrigine Into Breast Milk in Healthy Lactating Female Participants (clinicaltrials.gov) - Sep 10, 2026 - P1 | N=13 | Completed | Sponsor: Vertex Pharmaceuticals Incorporated | Recruiting ➔ Completed | Trial completion date: Feb 2027 ➔ Aug 2026 | Trial primary completion date: Feb 2027 ➔ Aug 2026 
Trial completion • Trial completion date • Trial primary completion date • Pain
http://clinicaltrials.gov/ct2/show/NCT07378865
 
Sep 10, 2026
 
Prev Next